| Joselito B Domingo, MD | |
|
59 Koch Ave, Morris Plains, NJ 07950-4400 | |
| (973) 538-1800 | |
| Not Available |
| Full Name | Joselito B Domingo |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 41 Years |
| Location | 59 Koch Ave, Morris Plains, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609936806 | NPI | - | NPPES |
| 887864C2E | Other | NJ | MEDICARE BILLING NO. |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA06012200 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Oaks Hospital Inc | 8628047685 | 6 |
News Archive
Many drugmakers have announced price increases with the start of the new year. The new Congress wants to do something about that. And even though both Republicans and Democrats want to address the politically potent issue of drug prices, it is unclear what they might be able to agree on.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
U.S. News & World Report/HealthDay News reports that seniors who participate in Medicare Part D's will likely notice significant changes during this year's open enrollment period, which begins Nov. 15. "Monthly premiums will rise 11 percent to $38.94, on average, according to an analysis published by the Henry J. Kaiser Family Foundation. That's up 50 percent from 2006, the first year that Medicare Part D drug benefits were offered."
For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases arise from these genetic miscues, about half of which are linked to the abnormal functioning of BRCA1.
› Verified 6 days ago
| Entity Name | State Of New Jersey Omb Centralized Payroll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336221878 PECOS PAC ID: 6406742592 Enrollment ID: O20040420000292 |
News Archive
Many drugmakers have announced price increases with the start of the new year. The new Congress wants to do something about that. And even though both Republicans and Democrats want to address the politically potent issue of drug prices, it is unclear what they might be able to agree on.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
U.S. News & World Report/HealthDay News reports that seniors who participate in Medicare Part D's will likely notice significant changes during this year's open enrollment period, which begins Nov. 15. "Monthly premiums will rise 11 percent to $38.94, on average, according to an analysis published by the Henry J. Kaiser Family Foundation. That's up 50 percent from 2006, the first year that Medicare Part D drug benefits were offered."
For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases arise from these genetic miscues, about half of which are linked to the abnormal functioning of BRCA1.
› Verified 6 days ago
| Entity Name | Summit Oaks Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205880200 PECOS PAC ID: 8628047685 Enrollment ID: O20051213000141 |
News Archive
Many drugmakers have announced price increases with the start of the new year. The new Congress wants to do something about that. And even though both Republicans and Democrats want to address the politically potent issue of drug prices, it is unclear what they might be able to agree on.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
U.S. News & World Report/HealthDay News reports that seniors who participate in Medicare Part D's will likely notice significant changes during this year's open enrollment period, which begins Nov. 15. "Monthly premiums will rise 11 percent to $38.94, on average, according to an analysis published by the Henry J. Kaiser Family Foundation. That's up 50 percent from 2006, the first year that Medicare Part D drug benefits were offered."
For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases arise from these genetic miscues, about half of which are linked to the abnormal functioning of BRCA1.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joselito B Domingo, MD 59 Koch Ave, Morris Plains, NJ 07950-4400 Ph: (973) 588-5300 | Joselito B Domingo, MD 59 Koch Ave, Morris Plains, NJ 07950-4400 Ph: (973) 538-1800 |
News Archive
Many drugmakers have announced price increases with the start of the new year. The new Congress wants to do something about that. And even though both Republicans and Democrats want to address the politically potent issue of drug prices, it is unclear what they might be able to agree on.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
U.S. News & World Report/HealthDay News reports that seniors who participate in Medicare Part D's will likely notice significant changes during this year's open enrollment period, which begins Nov. 15. "Monthly premiums will rise 11 percent to $38.94, on average, according to an analysis published by the Henry J. Kaiser Family Foundation. That's up 50 percent from 2006, the first year that Medicare Part D drug benefits were offered."
For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases arise from these genetic miscues, about half of which are linked to the abnormal functioning of BRCA1.
› Verified 6 days ago
Dr. Elda P Sancho Mora, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 59 Koch Ave, Morris Plains, NJ 07950 Phone: 973-538-1800 | |
Dr. Inderpal Kaur Bhathal, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 59 Koch Ave, Morris Plains, NJ 07950 Phone: 973-889-4390 Fax: 973-889-8799 | |
Dr. Edward Michael Collopy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 520 Speedwell Ave, Suite 108, Morris Plains, NJ 07950 Phone: 973-984-9100 Fax: 973-984-9181 | |
Dr. Anasuya Salem, M.D., M.P.H Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2839 Rte 10 E, 203, Morris Plains, NJ 07950 Phone: 973-928-3900 Fax: 973-928-3901 | |
Marie C. Rabanal, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 59 Koch Ave, Morris Plains, NJ 07950 Phone: 973-538-1800 | |
Victoria F. Cayetano, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 59 Koch Avenue, Morris Plains, NJ 07950 Phone: 973-538-1800 | |
Dr. Ritesha S Krishnappa, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 59 Koch Ave, Morris Plains, NJ 07950 Phone: 973-538-1800 |